Cargando…
Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative Neoplasms
The implications of stem cell heterogeneity for disease pathogenesis and therapy are poorly defined. JAK2V617F(+) myeloproliferative neoplasms (MPNs), harboring the same mutation in hematopoietic stem cells (HSCs), display diverse phenotypes, including polycythemia vera (PV), essential thrombocythem...
Autores principales: | Tong, Jingyuan, Sun, Ting, Ma, Shihui, Zhao, Yanhong, Ju, Mankai, Gao, Yuchen, Zhu, Ping, Tan, Puwen, Fu, Rongfeng, Zhang, Anqi, Wang, Ding, Wang, Di, Xiao, Zhijian, Zhou, Jiaxi, Yang, Renchi, Loughran, Stephen J., Li, Juan, Green, Anthony R., Bresnick, Emery H., Wang, Dong, Cheng, Tao, Zhang, Lei, Shi, Lihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613297/ https://www.ncbi.nlm.nih.gov/pubmed/33798424 http://dx.doi.org/10.1016/j.stem.2021.02.026 |
Ejemplares similares
-
The Hematopoietic Niche in Myeloproliferative Neoplasms
por: Schmitt-Graeff, Annette H., et al.
Publicado: (2015) -
Multilevel defects in the hematopoietic niche in essential thrombocythemia
por: Sun, Ting, et al.
Publicado: (2020) -
Targeted therapies for myeloproliferative neoplasms
por: Li, Bing, et al.
Publicado: (2019) -
Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cells
por: Lubberich, Richard K., et al.
Publicado: (2018) -
Inherited myeloproliferative neoplasm risk impacts hematopoietic stem cells
por: Bao, Erik L., et al.
Publicado: (2020)